88% Phenol vs 10% NaOH in the treatment of Ingrown toe-nail
- Conditions
- Health Condition 1: L600- Ingrowing nailHealth Condition 2: null- Patients with Ingrown toe nails
- Registration Number
- CTRI/2013/11/004164
- Lead Sponsor
- Research institution and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients with a clinical diagnosis of ingrown toenail, who are symptomatic presenting to the dermatology clinic of GTB hospital, with ages between 18 to 60 years.
2.Patients willing to participate in the study according to the protocol.
1.Those with significant peripheral arterial disease or history of chronic smoking
2.Known allergy to the chemical agents being used
3.Conditions associated with delayed wound healing e.g. Diabetes Mellitus.
4.Pregnant or lactating women.
5.Patients not consenting for surgical intervention or for inclusion in the study protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Time to complete healing: This will be recorded in terms of the number of days taken to achieve healing of the operated area defined as discharge (Grade 0); no evidence of tissue destruction; no raw areas or erosions.Timepoint: 1.Time to complete healing: This will be recorded in terms of the number of days taken to achieve healing of the operated area defined as discharge (Grade 0); no evidence of tissue destruction; no raw areas or erosions.
- Secondary Outcome Measures
Name Time Method 2.Cure: This will be defined as healing along with absence of pain (score 0). The number of patients cured within each group will be recorded.Timepoint: Assessed at each visit as per protocol.;3.Recurrence: All the patients will be followed up for a minimum period of one year. Any reappearance of pain, discharge, inflammation or swelling of the nail fold in a patient who had previously been cured will counted as a recurrence.Timepoint: Assessed at each visit (as per protocol) upto a maximum of ONE YEAR